Skip to main content
. 2007 Aug 23;110(13):4552–4559. doi: 10.1182/blood-2007-06-093880

Table 3.

Laboratory parameters monitored for immune recovery

Time after transplantation Patients younger than 50 y, n = 33 Patients 50 y or older, n = 19 All, n = 52
5 to 7 mo., no. evaluated/eligible 24/27 16/17 40/44
    CD4, %
        200 or more cells/μL 38 44 40
        Less than 100 cells/μL 25 13 20
    PHA, %
        Median 52 13 32
        Less than 25% LLN 33 69 48*
11 to 12 mo., no. evaluated/eligible 21/24 11/13 32/35
    CD4, %
        200 or more cells/μL 71 55 66
        Less than 100 cells/μL 10 9 9
    PHA, %
        Median 113 14 71
        Less than 25% LLN 0 64 22
15 to 18 mo., no. evaluated/eligible 17/23 10/10 27/33
    CD4, %
        200 or more cells/μL 71 90 82
        Less than 100 cells/μL 0 0 0
    PHA, %
        Median 129 37 100
        Less than 25% LLN 6 44 20*
24 mo., no. evaluated/eligible 12/21 4/7 16/28
    CD4, %
        200 or more cells/μL 83 75 81
        Less than 100 cells/μL 8 0 6
    PHA, %
        Median 126 22 103
        Less than 25% LLN 9 50 20

CD4 indicates the percentage of patients with an absolute CD4 count 200 or more or less than 100 cells/μL.

Each patient's PHA response was calculated as percentage = (patient response/LLN).

Less than 25% LLN indicates the percentage of patients with PHA responses less than 25% LLN.

*

P = .05

P < .01

P = .14